inVentiv Health is a global professional services organization that assists biopharmaceutical companies in accelerating the delivery of therapies to market. By integrating a clinical research organization (CRO) with a contract commercial organization (CCO), inVentiv Health provides a comprehensive suite of services designed to streamline processes and enhance efficiency. The company combines industry expertise with advanced technologies to eliminate obstacles that can delay product development and commercialization. With over 15,000 healthcare professionals operating in 90 countries, inVentiv Health has played a crucial role in the development and commercialization of a significant percentage of new drugs approved by regulatory agencies, including 80 percent of FDA approvals and 70 percent of EMA approvals in the last five years. This proven model positions inVentiv Health as a key partner for biopharmaceutical clients navigating an increasingly complex operating environment.
PharmaNet Development Group, a global, drug development services company, provides clinical development services including consulting, Phase I and bioequivalence clinical studies, Phase II-III clinical development programs, Phase IIIb-IV surveys, registries, and programs, as well as bioanalytical laboratory services through its subsidiaries Anapharm, Anapharm Europe, Keystone Analytical, and Taylor Technology.
RxCentric is an e-health company that specializes in providing online marketing solutions for pharmaceutical companies. It connects physicians with essential drug information and educational resources through a targeted digital platform. By offering rapid access to comprehensive and reliable drug information, RxCentric aims to enhance the educational needs of healthcare professionals and improve their decision-making processes regarding pharmaceutical products.
Helios Health are provides Web-based health information.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.